In 2000, the United States Food and Drug Administration first approved the use of mifepristone, a medication used in early, nonsurgical medication abortions. Since then states have passed laws to regulate access to medication abortion and the use of abortion-inducing drugs, including restrictions on the use of telemedicine for the procedure and medication reversal notification.
This dataset explores abortion regulations in all 50 U.S. states and the District of Columbia in effect from December 1, 2018 through November 1, 2022, as well as case law and attorney general opinions that affect the enforceability of these laws.
This dataset is a part of a suite of 17 datasets created by the Policy Surveillance Program of the Center for Public Health Law Research in collaboration with subject matter experts from Resources for Abortion Delivery (RAD), Guttmacher Institute, American Civil Liberties Union (ACLU), Center for Reproductive Rights (CRR), National Abortion Federation (NAF), and Planned Parenthood Federation of America (PPFA), who conceptualized and developed the Abortion Law Project. If you need broader contextual information on state laws and policies, national level information, or data and evidence related to abortion and other reproductive health issues, please contact the Guttmacher Institute at firstname.lastname@example.org.
Disclaimer: The information contained herein does not constitute legal advice. If you have questions regarding your legal rights or obligations, contact an attorney. If you are an abortion provider seeking legal compliance guidance, the following collaborating organizations may be able to assist you: ACLU, CRR, PPFA (for affiliated health centers), NAF, and Regulatory Assistance for Abortion Providers (a project of RAD).
If you have any questions about the information provided here, please contact LawAtlas@temple.edu or RAAP@radprogram.org.Read more...